MicroPort<sup>®</sup> EP Receives Approval to be Quoted on NEEQ

Shanghai, China - On July 28, Shanghai MicroPort EP MedTech Co., Ltd. ("MicroPort® EP") received approval notification relating to the quotation of the shares of MicroPort® EP on the National Equities Exchange and Quotations ("NEEQ").
 
MicroPort® EP primarily focuses on developing, manufacturing, and marketing of minimally invasive medical devices for the treatment of electrophysiological diseases, such as 3D cardiac mapping system, ablation catheter, and diagnosis catheter. The approval of quotation of MicroPort® EP on the NEEQ will enhance its corporate profile, enable it to have a better fund-raising platform, and increase its ability to attract strategic investors.